Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 29Breast Neoplasms 10Neoplasms 2Stage II Prostate Adenocarcinoma 1Salivary Gland Neoplasms 1Prostatectomy 1Prostate Cancer Metastatic Disease 1Ovarian Neoplasms 1Oligometastatic Prostate Carcinoma 1Metastatic Castration-resistant Prostate Cancer 1Highly Endocrine Responsive Operable Breast Cancer 1Cardiovascular Diseases 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Specimen Handling 1Radiotherapy 1Radiation 1Magnetic Resonance Spectroscopy 1Gonadotropin-Releasing Hormone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Oligometastatic Prostate Carcinoma × Gonadotropin-Releasing Hormone × Clear all
NCT06369610 2025-11-14

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

Mayo Clinic

Phase 2 Recruiting
110 enrolled
Genitourinary

Oligometastatic Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡